<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_IDM132 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEgr7 jpg ?><?FILEgr8 jpg ?><?FILEsi1 svg ?><?FILEsi2 svg ?><?FILEsi3 svg ?><?FILEsi4 svg ?><?FILEsi5 svg ?><?FILEsi6 svg ?><?FILEsi7 svg ?><?FILEsi8 svg ?><?FILEsi9 svg ?><?FILEsi10 svg ?><?FILEsi11 svg ?><?FILEsi12 svg ?><?FILEsi13 svg ?><?FILEsi14 svg ?><?FILEsi15 svg ?><?FILEsi16 svg ?><?FILEsi17 svg ?><?FILEsi18 svg ?><?FILEsi19 svg ?><?FILEsi20 svg ?><?FILEsi21 svg ?><?FILEsi22 svg ?><?FILEsi23 svg ?><?FILEsi24 svg ?><?FILEsi25 svg ?><?FILEsi26 svg ?><?FILEsi27 svg ?><?FILEsi28 svg ?><?FILEsi29 svg ?><?FILEsi30 svg ?><?FILEsi31 svg ?><?FILEsi32 svg ?><?FILEsi33 svg ?><?FILEsi34 svg ?><?FILEsi35 svg ?><?FILEsi36 svg ?><?FILEsi37 svg ?><?FILEsi38 svg ?><?FILEsi39 svg ?><?FILEsi40 svg ?><?FILEsi41 svg ?><?FILEsi42 svg ?><?FILEsi43 svg ?><?FILEsi44 svg ?><?FILEsi45 svg ?><?FILEsi46 svg ?><?FILEsi47 svg ?><?FILEsi48 svg ?><?FILEsi49 svg ?><?FILEsi50 svg ?><?FILEsi51 svg ?><?FILEsi52 svg ?><?FILEsi53 svg ?><?FILEsi54 svg ?><?FILEsi55 svg ?><?FILEsi56 svg ?><?FILEsi57 svg ?><?FILEsi58 svg ?><?FILEsi59 svg ?><?FILEsi60 svg ?><?FILEsi61 svg ?><?FILEsi62 svg ?><?FILEsi63 svg ?><?FILEsi64 svg ?><?FILEsi65 svg ?><?FILEsi66 svg ?><?FILEsi67 svg ?><?FILEsi68 svg ?><?FILEsi69 svg ?><?FILEsi70 svg ?><?FILEsi71 svg ?><?FILEsi72 svg ?><?FILEsi73 svg ?><?FILEsi74 svg ?><?FILEsi75 svg ?><?FILEsi76 svg ?><?FILEsi77 svg ?><?FILEsi78 svg ?><?FILEsi79 svg ?><?FILEsi80 svg ?><?FILEsi81 svg ?><?FILEsi82 svg ?><?FILEsi83 svg ?><?FILEsi84 svg ?><?FILEsi85 svg ?><?FILEsi86 svg ?><?FILEsi87 svg ?><?FILEsi88 svg ?><?FILEsi89 svg ?><?FILEsi90 svg ?><?FILEsi91 svg ?><?FILEsi92 svg ?><?FILEsi93 svg ?><?FILEsi94 svg ?><?FILEsi95 svg ?><?FILEsi96 svg ?><?FILEsi97 svg ?><?FILEsi98 svg ?><?FILEsi99 svg ?><?FILEsi100 svg ?><?FILEsi101 svg ?><?FILEsi102 svg ?><?FILEsi103 svg ?><?FILEsi104 svg ?><?FILEsi105 svg ?><?FILEsi106 svg ?><?FILEsi107 svg ?><?FILEsi108 svg ?><?FILEsi109 svg ?><?FILEsi110 svg ?><?FILEsi111 svg ?><?FILEsi112 svg ?><?FILEsi113 svg ?><?FILEsi114 svg ?><?FILEsi115 svg ?><?FILEsi116 svg ?><?FILEsi117 svg ?><?FILEsi118 svg ?><?FILEsi119 svg ?><?FILEsi120 svg ?><?FILEsi121 svg ?><?FILEsi122 svg ?><?FILEsi123 svg ?><?FILEsi124 svg ?><?FILEsi125 svg ?><?FILEsi126 svg ?><?FILEsi127 svg ?><?FILEsi128 svg ?><?FILEsi129 svg ?><?FILEsi130 svg ?><?FILEsi131 svg ?><?FILEsi132 svg ?><?FILEsi133 svg ?><?FILEsi134 svg ?><?FILEsi135 svg ?><?FILEsi136 svg ?><?FILEsi137 svg ?><?FILEsi138 svg ?><?FILEsi139 svg ?><?FILEsi140 svg ?><?FILEsi141 svg ?><?FILEsi142 svg ?><?FILEsi143 svg ?><?FILEsi144 svg ?><?FILEsi145 svg ?><?FILEsi146 svg ?><?FILEsi148 svg ?><?FILEsi150 svg ?><?FILEsi151 svg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Model</journal-id><journal-id journal-id-type="iso-abbrev">Infect Dis Model</journal-id><journal-title-group><journal-title>Infectious Disease Modelling</journal-title></journal-title-group><issn pub-type="ppub">2468-2152</issn><issn pub-type="epub">2468-0427</issn><publisher><publisher-name>KeAi Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7409819</article-id><article-id pub-id-type="publisher-id">S2468-0427(20)30030-0</article-id><article-id pub-id-type="doi">10.1016/j.idm.2020.07.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Special issue on Modelling and Forecasting the 2019 Novel Coronavirus (2019-nCoV) Transmission; Edited by Prof. Carlos Castillo-Chavez, Prof. Gerardo Chowell-Puente, Prof. Ping Yan, Prof. Jianhong Wu</subject></subj-group></article-categories><title-group><article-title>Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Iboi</surname><given-names>Enahoro A.</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Ngonghala</surname><given-names>Calistus N.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Gumel</surname><given-names>Abba B.</given-names></name><email>agumel@asu.edu</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>School of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, 85287, USA</aff><aff id="aff2"><label>b</label>Department of Mathematics, University of Florida, Gainesville, FL, 32611, USA</aff><aff id="aff3"><label>c</label>Department of Mathematics and Applied Mathematics, University of Pretoria, Pretoria, 0002, South Africa</aff><aff id="aff4"><label>d</label>Department of Mathematics, Spelman College, Atlanta, Georgia, 30314, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. School of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, 85287, USA. <email>agumel@asu.edu</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>06</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>8</month><year>2020</year></pub-date><volume>5</volume><fpage>510</fpage><lpage>524</lpage><history><date date-type="received"><day>9</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>The novel coronavirus (COVID-19) that emerged from Wuhan city of China in late December 2019 continue to pose devastating public health and economic challenges across the world. Although the community-wide implementation of basic non-pharmaceutical intervention measures, such as social distancing, quarantine of suspected COVID-19 cases, isolation of confirmed cases, use of face masks in public, contact tracing and testing, have been quite effective in curtailing and mitigating the burden of the pandemic, it is universally believed that the use of a vaccine may be necessary to effectively curtail and eliminating COVID-19 in human populations. This study is based on the use of a mathematical model for assessing the impact of a hypothetical imperfect anti-COVID-19 vaccine on the control of COVID-19 in the United States. An analytical expression for the minimum percentage of unvaccinated susceptible individuals needed to be vaccinated in order to achieve vaccine-induced community herd immunity is derived. The epidemiological consequence of the herd immunity threshold is that the disease can be effectively controlled or eliminated if the minimum herd immunity threshold is achieved in the community. Simulations of the model, using baseline parameter values obtained from fitting the model with COVID-19 mortality data for the U.S., show that, for an anti-COVID-19 vaccine with an assumed protective efficacy of 80%, at least 82% of the susceptible US population need to be vaccinated to achieve the herd immunity threshold. The prospect of COVID-19 elimination in the US, using the hypothetical vaccine, is greatly enhanced if the vaccination program is combined with other interventions, such as face mask usage and/or social distancing. Such combination of strategies significantly reduces the level of the vaccine-induced herd immunity threshold needed to eliminate the pandemic in the US. For instance, the herd immunity threshold decreases to 72% if half of the US population regularly wears face masks in public (the threshold decreases to 46% if everyone wears a face mask).</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>Vaccination</kwd><kwd>Social distancing</kwd><kwd>Non-pharmaceutical intervention</kwd></kwd-group></article-meta><notes><p id="misc0010">Handling Editor: Dr. J Wu</p></notes></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">In December 2019, the Wuhan Municipal Health Commission, China, reported a cluster of a pneumonia-like illness, caused by a coronavirus (SARS-CoV-2) in Wuhan, Hubei Province of China (<xref rid="bib21" ref-type="bibr">Li et&#x000a0;al., 2020</xref>; <xref rid="bib29" ref-type="bibr">World Health Organization, 2020a</xref>; <xref rid="bib32" ref-type="bibr">World Health Organization</xref>). The disease rapidly spread to many countries, resulting in the <xref rid="bib32" ref-type="bibr">World Health Organization</xref> declaring the novel coronavirus (COVID-19) as a pandemic on March 11, 2020 (<xref rid="bib24" ref-type="bibr">Ngonghala et&#x000a0;al., 2020</xref>; <xref rid="bib29" ref-type="bibr">World Health Organization, 2020a</xref>; <xref rid="bib32" ref-type="bibr">World Health Organization</xref>). As of June 28, 2020, COVID-19 has caused over 10 million confirmed cases and 500,000 fatalities globally. The United States, which is now the epicenter of COVID-19, recorded over 2.5 million confirmed cases and 125,000 deaths (&#x0201c;<xref rid="bib5" ref-type="bibr">Center for Systems Scien, 2020</xref>). While some people infected with COVID-19 experience mild symptoms of the disease (such as fever, coughing and shortness of breath), others develop severe disease and complications (causing acute respiratory failure, which damages the lungs and often cause death) (<xref rid="bib19" ref-type="bibr">Knvul and Katie, 2020</xref>; <xref rid="bib24" ref-type="bibr">Ngonghala et&#x000a0;al., 2020</xref>; <xref rid="bib31" ref-type="bibr">World Health Organization, 2020b</xref>). In addition to the devastating public health burden it induced in the US, COVID-19 has also inflicted severe economic hardship, causing a decrease in both human and economic productivity (translating to about 30% unemployment rate, and a projected 50% decline in GDP by the summer of 2020 (<xref rid="bib22" ref-type="bibr">Matthews, 2020</xref>; <xref rid="bib26" ref-type="bibr">Rotman, 2020</xref>)).</p><p id="p0015">There are currently no approved vaccines and effective therapies for use against COVID-19. Hence, control efforts against COVID-19 are focused on using basic non-pharmaceutical interventions (NPIs), such as social distancing, quarantine of people suspected of being exposed to COVID-19, isolation of confirmed cases, use of face masks in public and contact-tracing (<xref rid="bib24" ref-type="bibr">Ngonghala et&#x000a0;al., 2020</xref>; <xref rid="bib14" ref-type="bibr">Ferguson et&#x000a0;al., 2020</xref>; <xref rid="bib13" ref-type="bibr">Eikenberry et&#x000a0;al., 2020</xref>). There is now a concerted global effort to develop a safe and effective anti-COVID-19 vaccine to help combat the COVID-19 pandemic. Although the development of new vaccines generally take years, a number of pharmaceutical companies, with support from numerous government agencies and regulatory authorities, are doing everything possible to fast-track the availability of a safe and effective vaccine against COVID-19. Over a dozen organizations have announced plans to start efficacy testing for their candidate vaccines (<xref rid="bib19" ref-type="bibr">Knvul and Katie, 2020</xref>; <xref rid="bib4" ref-type="bibr">Callaway, 2020</xref>; <xref rid="bib18" ref-type="bibr">Kirkpatrick, 2020</xref>). In fact, scientists at the Jenner Institute at the Oxford University have developed a new coronavirus vaccine that is undergoing early-phase trials, and they expect the first few million doses of their vaccine to be widely available as early as September 2020 (<xref rid="bib4" ref-type="bibr">Callaway, 2020</xref>; <xref rid="bib18" ref-type="bibr">Kirkpatrick, 2020</xref>). A Maryland-based biotechnology company <italic>Novavax</italic> has begun human clinical trials for its candidate vaccine in Australia (<xref rid="bib19" ref-type="bibr">Knvul and Katie, 2020</xref>). Similarly, <italic>Mesoblast</italic>, a company supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> (<funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source>), started a 240-patient clinical trial aimed at testing whether cells derived from bone marrow could help patients who developed a deadly immune reaction to the coronavirus (<xref rid="bib19" ref-type="bibr">Knvul and Katie, 2020</xref>). Thus, there is an urgent need to develop and use mathematical models to assess the population-level impact of a future hypothetical vaccine against COVID-19. This forms the objective of the current study.</p><p id="p0020">Numerous mathematical models have been developed and used to study the transmission dynamics and control of COVID-19. For instance, an agent-based model was developed by Ferguson et&#x000a0;al. (<xref rid="bib14" ref-type="bibr">Ferguson et&#x000a0;al., 2020</xref>) to investigate the impact of NPIs on COVID-19-induced mortality, showing an alarming worst-case projection of number of cases for the US and Great Britain (at the tune of 81%). Eikenberry et&#x000a0;al. (<xref rid="bib13" ref-type="bibr">Eikenberry et&#x000a0;al., 2020</xref>) developed a multi-group model for assessing the community-wide impact of mask use by the general, asymptomatic public, a portion of which may be asymptomatically-infectious. The study shows that the use of face masks by members of the general public is potentially of high value in curtailing community transmission and the burden of the pandemic, and that the community-wide benefits are likely to be greatest when face masks are used in conjunction with other non-pharmaceutical practices (such as social distancing), and when adoption is nearly universal (nation-wide) and compliance is high. Ngonghala et&#x000a0;al. (<xref rid="bib24" ref-type="bibr">Ngonghala et&#x000a0;al., 2020</xref>) developed a comprehensive model for assessing the impact of the major NPIs (quarantine, isolation, social distancing, face mask usage in public, testing and contact-tracing) on the control of COVID-19. Their study estimated that, while the early relaxation or lifting social distancing measures and mask usage is likely to lead to second wave, the extended adherence to the current social distancing and mask usage can significantly reduce COVID-induced mortality in the US in general, and the state of New York in particular.</p><p id="p0025">Mizumoto and Chowell (<xref rid="bib23" ref-type="bibr">Mizumoto &#x00026; Chowell, 2020</xref>) modeled the potential for a COVID-19 outbreak in the Diamond Princess cruise ship. Their study showed an estimate of a higher reproduction number, which substantially decreases with increasing effectiveness of quarantine measures on the ship. A stochastic model was developed by Hellewell et&#x000a0;al. (<xref rid="bib16" ref-type="bibr">Hellewell et&#x000a0;al., 2020</xref>) to assess the impact of contact-tracing and isolation on disease control. Their study suggests that (for most instances) the spread of COVID-19 can be effectively contained in 3 months if the two control measures (contact-tracing and isolation) are highly effective. Kucharski et&#x000a0;al. (<xref rid="bib20" ref-type="bibr">Kucharski et&#x000a0;al., 2020</xref>) also developed a stochastic model to assess the COVID-19 trajectory in Wuhan from January to February 2020, showing a reduction in transmission when travel restrictions were implemented. Li et&#x000a0;al. developed a mathematical model to assess the effect of mass influenza vaccination on the spread of COVID-19 and other influenza-like pathogens co-circulating during an influenza season. Their study showed that increasing influenza vaccine uptake, or enhancing the public health interventions, would facilitate the management of outbreaks of respiratory pathogens circulating during the peak flu season.</p><p id="p0030">The current study is based on the design of a mathematical model to assess the impact of an anti-COVID-19 vaccine on the transmission dynamics of the COVID-19 pandemic in the United States. COVID-19 mortality data for the US will be used to fit the model, and to estimate the unknown parameters of the model (notably the contact rate parameters).</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Model formulation</title><p id="p0035">This study is based on the development of a relatively standard mathematical model for assessing the population-level impact of a potential hypothetical anti-COVID-19 vaccine in a community. The model is developed by splitting the total human population at time <italic>t</italic>, denoted by <inline-formula><mml:math id="M1" altimg="si1.svg"><mml:mrow><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, into the mutually-exclusive compartments of unvaccinated susceptible (<inline-formula><mml:math id="M2" altimg="si2.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>, vaccinated susceptible (<inline-formula><mml:math id="M3" altimg="si3.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>, early-exposed (<inline-formula><mml:math id="M4" altimg="si4.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>; i.e., newly-exposed individuals), pre-symptomatic infectious (<inline-formula><mml:math id="M5" altimg="si5.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), symptomatically-infectious (<inline-formula><mml:math id="M6" altimg="si6.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, asymptomatically-infectious (<inline-formula><mml:math id="M7" altimg="si7.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>, hospitalized (<inline-formula><mml:math id="M8" altimg="si8.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> and recovered (<inline-formula><mml:math id="M9" altimg="si9.svg"><mml:mrow><mml:mi>R</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> individuals. Thus,<disp-formula id="ufd1"><mml:math id="M10" altimg="si10.svg"><mml:mrow><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>R</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0040">It should be emphasized that individuals in the <inline-formula><mml:math id="M11" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> compartment are those newly-infected individuals that are close to surviving the incubation period, and are shedding the virus. Hence, they are infectious (i.e., they are able to transmit COVID-19 infection to susceptible individuals). Furthermore, while individuals in the <inline-formula><mml:math id="M12" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> are those that show moderate to severe symptoms of COVID-19 at the end of the incubation period, those in the <inline-formula><mml:math id="M13" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> compartment are assumed to show mild or no clinical symptoms of the disease at the end of the incubation period. The compartment <inline-formula><mml:math id="M14" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> also contains individuals with clinical symptoms of COVID-19 who are hospitalized or self-isolated at home.</p><p id="p0045">The model is given by the following deterministic system of nonlinear differential equations, where a dot represents differentiation with respect to time <italic>t</italic> (a flow diagram of the model is depicted in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>. The state variables and parameters of the model are described in <xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="tbl2" ref-type="table">Table 2</xref>, respectively):<disp-formula id="fd2_1"><label>(2.1)</label><mml:math id="M15" display="block" altimg="si15.svg" alttext="Equation 2.1."><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>u</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>r</mml:mi><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mspace width="0.25em"/><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>where the <italic>forces of infection</italic>
<inline-formula><mml:math id="M16" altimg="si16.svg"><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M17" altimg="si17.svg"><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> are defined below<disp-formula id="fd2_2"><label>(2.2)</label><mml:math id="M18" display="block" altimg="si18.svg" alttext="Equation 2.2."><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula><fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>Flow diagram of the model (2.1).</p></caption><alt-text id="alttext0010">Fig.&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Description of state variables of the model (2.1).</p></caption><alt-text id="alttext0050">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th><bold>State variable</bold></th><th><bold>Description</bold></th></tr></thead><tbody><tr><td align="left"><inline-formula><mml:math id="M19" altimg="si45.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of unvaccinated susceptible individuals</td></tr><tr><td align="left"><inline-formula><mml:math id="M20" altimg="si46.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of vaccinated susceptible individuals</td></tr><tr><td align="left"><inline-formula><mml:math id="M21" altimg="si27.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of early-exposed individuals (i.e., newly-infected individuals who are not yet infectious)</td></tr><tr><td align="left"><inline-formula><mml:math id="M22" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of pre-symptomatic infectious individuals (i.e., exposed individuals who are close to surviving the incubation period and are shedding virus)</td></tr><tr><td align="left"><inline-formula><mml:math id="M23" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of symptomatically-infectious individuals (who display moderate or severe symptoms of the disease at the end of the incubation period)</td></tr><tr><td align="left"><inline-formula><mml:math id="M24" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of asymptomatically-infectious individuals (who display mild or no clinical symptoms of the disease at the end of the incubation period)</td></tr><tr><td align="left"><inline-formula><mml:math id="M25" altimg="si14.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Population of hospitalized individuals</td></tr><tr><td align="left"><italic>R</italic></td><td align="left">Population of recovered individuals</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Description of the parameters of the model (2.1).</p></caption><alt-text id="alttext0055">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th><bold>Parameter</bold></th><th><bold>Description</bold></th></tr></thead><tbody><tr><td align="left"><inline-formula><mml:math id="M26" altimg="si38.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula></td><td align="left">Effective community contact rate (a measure of social distancing effectiveness)</td></tr><tr><td align="left"><inline-formula><mml:math id="M27" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Proportion of members of public who wear masks in public (i.e., face masks compliance)</td></tr><tr><td align="left"><inline-formula><mml:math id="M28" altimg="si48.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Efficacy of face masks to prevent acquisition of infection by susceptible individuals</td></tr><tr><td align="left"><inline-formula><mml:math id="M29" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Vaccination rate</td></tr><tr><td align="left"><inline-formula><mml:math id="M30" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Vaccine efficacy against acquisition of infection (degree protection)</td></tr><tr><td align="left">r</td><td align="left">Proportion of pre-symptomatic individuals who do not show clinical symptoms of COVID-19 at the end of the incubation period</td></tr><tr><td align="left"><inline-formula><mml:math id="M31" altimg="si50.svg"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:math></inline-formula></td><td align="left">Proportion of pre-symptomatic infectious individuals who show clinical symptoms of COVID-19 at the end of the incubation period</td></tr><tr><td align="left"><inline-formula><mml:math id="M32" altimg="si26.svg"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Rate of progression from early-exposed class (<inline-formula><mml:math id="M33" altimg="si27.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) to the pre-symptomatic class</td></tr><tr><td align="left"><inline-formula><mml:math id="M34" altimg="si29.svg"><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Rate of progression from pre-symptomatic class (<inline-formula><mml:math id="M35" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) to asymptomatically-infectious class</td></tr><tr><td align="left"><inline-formula><mml:math id="M36" altimg="si31.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Rate of progression from pre-symptomatic class (<inline-formula><mml:math id="M37" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) to symptomatically-infectious class</td></tr><tr><td align="left"><inline-formula><mml:math id="M38" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">Hospitalization rate for infectious individuals</td></tr><tr><td align="left"><inline-formula><mml:math id="M39" altimg="si33.svg"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula></td><td align="left">Recovery rate for individuals in the <inline-formula><mml:math id="M40" altimg="si34.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> class</td></tr><tr><td align="left"><inline-formula><mml:math id="M41" altimg="si36.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula></td><td align="left">Disease-induced mortality rate for infectious individuals in the <inline-formula><mml:math id="M42" altimg="si37.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> class</td></tr></tbody></table></table-wrap></p><p id="p0050">In the model (2.1), unvaccinated susceptible individuals acquire COVID-19 infection, following effective contacts with individuals in the <inline-formula><mml:math id="M43" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M44" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M45" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> classes, at the rates <inline-formula><mml:math id="M46" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M47" altimg="si20.svg"><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M48" altimg="si17.svg"><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, respectively. Unvaccinated susceptible individuals are vaccinated at a <italic>per capita</italic> rate <inline-formula><mml:math id="M49" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. It is assumed that the hypothetical anti-COVID-19 vaccine is imperfect. Hence, the vaccine allows for breakthrough infected in vaccinated susceptible individuals who became infected with COVID-1), with a protective efficacy <inline-formula><mml:math id="M50" altimg="si22.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> (i.e., vaccinated susceptible individuals are assumed to acquire COVID-19 infection, following effective contact with individuals in the <inline-formula><mml:math id="M51" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M52" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M53" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> classes at the reduced rates, <inline-formula><mml:math id="M54" altimg="si23.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M55" altimg="si24.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M56" altimg="si25.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, respectively).</p><p id="p0055">The parameter <inline-formula><mml:math id="M57" altimg="si26.svg"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> represents the progression rate of individuals in the early-exposed class (i.e., individuals in the <inline-formula><mml:math id="M58" altimg="si27.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> class) to the pre-symptomatic infectious class (<inline-formula><mml:math id="M59" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>). Similarly, <inline-formula><mml:math id="M60" altimg="si28.svg"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> is the rate at which pre-symptomatic individuals progress, at the end of the incubation period, to either the asymptomatically-infectious class, <inline-formula><mml:math id="M61" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> (at a rate <inline-formula><mml:math id="M62" altimg="si29.svg"><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>; where <inline-formula><mml:math id="M63" altimg="si30.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mi>r</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> is the proportion of pre-symptomatic infectious individuals who do not show clinical symptoms of COVID-19 at the end of the incubation period) or to the symptomatically-infectious class, <inline-formula><mml:math id="M64" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> (at a rate <inline-formula><mml:math id="M65" altimg="si31.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>). Thus, the intrinsic incubation period of COVID-19 is given by <inline-formula><mml:math id="M66" altimg="si32.svg"><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak" linebreakstyle="after">+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>. The parameter <inline-formula><mml:math id="M67" altimg="si33.svg"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> represents the recovery rate for individuals in the <inline-formula><mml:math id="M68" altimg="si34.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> class. Similarly, <inline-formula><mml:math id="M69" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the hospitalization (or self-isolation) rate of individuals with clinical symptoms of COVID-19. Finally, the parameter <inline-formula><mml:math id="M70" altimg="si36.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> represents the COVID-induced mortality rate for individuals in the <inline-formula><mml:math id="M71" altimg="si37.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> class. It should be mentioned that, since not much data is available on the expected properties of a future anti-COVID-19 vaccine, we do not assume that the vaccine offers any therapeutic benefits. Further, we do not assume that the vaccine wanes during the one-year time period we would choose for the numerical simulations of our model.</p><p id="p0060">In <xref rid="fd2_2" ref-type="disp-formula">(2.2)</xref>, the parameter <inline-formula><mml:math id="M72" altimg="si38.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> represents the effective contact rate (i.e., contacts capable of leading to COVID-19 transmission) for pre-symptomatically-infectious (symptomatically-infectious) (asymptomatically-infectious) individuals, <inline-formula><mml:math id="M73" altimg="si39.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> is the proportion of members of the public who wear face masks (correctly and consistently) in public and <inline-formula><mml:math id="M74" altimg="si40.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> is the efficacy of the face masks. This formulation (i.e., <inline-formula><mml:math id="M75" altimg="si41.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02260;</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02260;</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) allows us to account for the possible heterogeneity in the contact rates of infectious individuals in the pre-symptomatic (<inline-formula><mml:math id="M76" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>), symptomatic (<inline-formula><mml:math id="M77" altimg="si42.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> and asymptomatic (<inline-formula><mml:math id="M78" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) classes. The basic model (2.1) may be the first to explicitly incorporates a hypothetical imperfect vaccine in a deterministic modeling study on COVID-19 dynamics.</p><p id="p0065">It is convenient, for housekeeping purposes, to define the following equation for the rate of change of the population of COVID-deceased individuals in the community (denoted by <inline-formula><mml:math id="M79" altimg="si43.svg"><mml:mrow><mml:mi>D</mml:mi><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>:<disp-formula id="fd2_3"><label>(2.3)</label><mml:math id="M80" display="block" altimg="si44.svg" alttext="Equation 2.3."><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p></sec></sec><sec id="sec3"><label>3</label><title>Theoretical analysis</title><sec id="sec3.1"><label>3.1</label><title>Asymptotic stability of disease-free equilibria</title><p id="p0070">The model (2.1) has a continuum (or line) of disease-free equilibria (DFE), given by<disp-formula id="ufd2"><mml:math id="M81" altimg="si51.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="0.25em"/><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>E</mml:mi><mml:mn>1</mml:mn><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>E</mml:mi><mml:mn>2</mml:mn><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>I</mml:mi><mml:mi>s</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>I</mml:mi><mml:mi>a</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>I</mml:mi><mml:mi>h</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mn>0,0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M82" altimg="si52.svg"><mml:mrow><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is the initial total population size, <inline-formula><mml:math id="M83" altimg="si53.svg"><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M84" altimg="si54.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="goodbreak" linebreakstyle="after">+</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:math></inline-formula>. The next generation operator method (<xref rid="bib12" ref-type="bibr">van den Driessche &#x00026; Watmough, 2002</xref>; <xref rid="bib9" ref-type="bibr">Diekmann et&#x000a0;al., 1990</xref>) can be used to analyse the asymptotic stability property of the continuum of disease-free equilibria, <inline-formula><mml:math id="M85" altimg="si55.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. In particular, using the notation in (<xref rid="bib12" ref-type="bibr">van den Driessche &#x00026; Watmough, 2002</xref>), it follows that the associated next generation matrices, <italic>F</italic> and <italic>V</italic>, for the new infection terms and the transition terms, are given, respectively, by<disp-formula id="ufd3"><mml:math id="M86" altimg="si56.svg"><mml:mrow><mml:mi>F</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:math></disp-formula>and,<disp-formula id="ufd4"><mml:math id="M87" altimg="si57.svg"><mml:mi>V</mml:mi><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mtd><mml:mtd><mml:mn>0</mml:mn><mml:mspace/></mml:mtd><mml:mtd><mml:mn>0</mml:mn><mml:mspace/></mml:mtd><mml:mtd><mml:mn>0</mml:mn><mml:mspace/></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mtd><mml:mtd><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mo>&#x02212;</mml:mo><mml:mfenced><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:mfenced><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mtd><mml:mtd><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mo>&#x02212;</mml:mo><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo>,</mml:mo></mml:math></disp-formula>where,<disp-formula id="ufd5"><mml:math id="M88" altimg="si58.svg"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="p0075">It is convenient to define the quantity <inline-formula><mml:math id="M89" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> by (with &#x003c1; being the spectral radius):<disp-formula id="fd3_1"><label>(3.1)</label><mml:math id="M90" display="block" altimg="si60.svg" alttext="Equation 3.1."><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mi>&#x003c1;</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>F</mml:mi><mml:msup><mml:mi>V</mml:mi><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where,<disp-formula id="fd3_2"><label>(3.2)</label><mml:math id="M91" display="block" altimg="si61.svg" alttext="Equation 3.2."><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="p0080">The quantity <inline-formula><mml:math id="M92" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the <italic>control reproduction number</italic> of the model (2.1). It measures the average number of new COVID-19 cases generated by a typical infectious individual introduced into a population where a certain fraction wears face masks in public and/or are vaccinated using the hypothetical imperfect vaccine. It is the sum of the constituent reproduction numbers associated with the number of new cases generated by pre-symptomatically-infectious humans (<inline-formula><mml:math id="M93" altimg="si62.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>, symptomatically-infectious humans (<inline-formula><mml:math id="M94" altimg="si63.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula>, and asymptomatically-infectious (<inline-formula><mml:math id="M95" altimg="si64.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> individuals. The reproduction number <inline-formula><mml:math id="M96" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is epidemiologically interpreted below.</p><sec id="sec3.1.1"><label>3.1.1</label><title>Interpretation of the control reproduction number</title><p id="p0085">As stated above, the control reproduction number <inline-formula><mml:math id="M97" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the sum of the three constituent reproduction numbers, <inline-formula><mml:math id="M98" altimg="si65.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M99" altimg="si66.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M100" altimg="si67.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>. The constituent reproduction number <inline-formula><mml:math id="M101" altimg="si65.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is given by the product of the infection rate of unvaccinated and vaccinated susceptible individuals by pre-symptomatically-infectious humans (near the continuum of disease-free equilibria), <inline-formula><mml:math id="M102" altimg="si68.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, the proportion of exposed individuals that survived the pre-exposed period and moved to the pre-symptomatically-infectious class and the average duration in the pre-symptomatically-infectious class <inline-formula><mml:math id="M103" altimg="si69.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Similarly, the constituent reproduction number <inline-formula><mml:math id="M104" altimg="si66.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is given by the product of the infection rate of unvaccinated and vaccinated susceptible individuals by symptomatically-infectious humans (near the continuum of disease-free equilibria), <inline-formula><mml:math id="M105" altimg="si70.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, the proportion of exposed individuals that survived the incubation period and moved to the symptomatically-infectious class <inline-formula><mml:math id="M106" altimg="si71.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and the average duration in the asymptomatically-infectious class <inline-formula><mml:math id="M107" altimg="si72.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Finally, the constituent reproduction number <inline-formula><mml:math id="M108" altimg="si67.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is given by the product of the infection rate of unvaccinated and vaccinated susceptible individuals (near the continuum of disease-free equilibria), <inline-formula><mml:math id="M109" altimg="si73.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, the proportion that survived the exposed class and moved to the asymptomatically-infectious class <inline-formula><mml:math id="M110" altimg="si74.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">=</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and the average duration in the <inline-formula><mml:math id="M111" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> class <inline-formula><mml:math id="M112" altimg="si75.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. The sum of <inline-formula><mml:math id="M113" altimg="si65.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M114" altimg="si66.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M115" altimg="si67.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> gives. <inline-formula><mml:math id="M116" altimg="si76.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></inline-formula></p><p id="p0090">The result below follows from the next generation matrix operator method of (<xref rid="bib12" ref-type="bibr">van den Driessche &#x00026; Watmough, 2002</xref>).<statement id="enun_Theorem_3_1"><label>Theorem 3.1</label><p id="p0095"><italic>The continuum of disease-free equilibria</italic> (<inline-formula><mml:math id="M117" altimg="si55.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <italic>of the model</italic> (2.1) <italic>is locally-asymptotically stable if</italic>
<inline-formula><mml:math id="M118" altimg="si77.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. <italic>If</italic>
<inline-formula><mml:math id="M119" altimg="si78.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, <italic>the epidemic first grows</italic>, <italic>reaches a peak</italic>, <italic>and then decreases to zero as</italic>
<inline-formula><mml:math id="M120" altimg="si79.svg"><mml:mrow><mml:mi>t</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02192;</mml:mo><mml:mi mathvariant="normal">&#x0221e;</mml:mi></mml:mrow></mml:math></inline-formula>.</p></statement></p><p id="p0100">The epidemiological implication of <xref rid="enun_Theorem_3_1" ref-type="statement">Theorem 3.1</xref> is that a small influx of COVID-19 cases will not generate a COVID-19 outbreak if the control reproduction number <inline-formula><mml:math id="M121" altimg="si80.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is less than unity (i.e., the epidemic dies out rapidly whenever <inline-formula><mml:math id="M122" altimg="si77.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>). It should be mentioned that, for epidemic models such as (2.1), the epidemiological requirement <inline-formula><mml:math id="M123" altimg="si77.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> is only sufficient, but not necessary, for the elimination of the epidemic. This is owing to the fact that, for such models (i.e., Kermack-McKendrick epidemic models with no vital/demographic dynamics), the disease always dies out with time (regardless of the value of the reproduction number of the models). In other words, even if <inline-formula><mml:math id="M124" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> exceeds unity, the disease will eventually die out. This is because (if <inline-formula><mml:math id="M125" altimg="si78.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>), the epidemic rises (exponentially, initially) and reach a peak. Subsequently, a combination of factors, such as the implementation of control measures in the community and the natural infection-acquired immunity in the community, will greatly curtail the epidemic to the extent that sustained community transmission is not feasible (and the disease dies out) (<xref rid="bib25" ref-type="bibr">Nishiura &#x00026; Chowell, 2009</xref>). It is worth stressing that, in the formulation of the model (2.1), we assumed that individuals who survived the COVID-19 infection develop permanent natural immunity against future COVID-19 infection (since there is no transition from the recovered to the susceptible class in the model). This natural immunity builds up in the community and contributes in protecting the rest of the susceptible population from acquiring COVID-19 infection. If recruitment of susceptible individuals is allowed (e.g., in the case where an endemic model is used), the disease will persist in the population when <inline-formula><mml:math id="M126" altimg="si78.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> (this is because the pool of new completely-susceptible, or COVID-19-naive, individuals will continuously be replenished, by birth or immigration, thereby allowing the disease to sustain itself in the community).</p><p id="p0105">It is convenient to define the following feasible (positively-invariant and attracting) region for the model (2.1)<disp-formula id="ufd6"><mml:math id="M127" altimg="si81.svg"><mml:mrow><mml:mtext>&#x003a9;</mml:mtext><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>R</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02208;</mml:mo><mml:msubsup><mml:mi mathvariant="double-struck">R</mml:mi><mml:mo linebreak="badbreak">+</mml:mo><mml:mn>8</mml:mn></mml:msubsup><mml:mo>:</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mi>R</mml:mi><mml:mo linebreak="badbreak">&#x02264;</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0110">We claim the following result:<statement id="enun_Theorem_3_2"><label>Theorem 3.2</label><p id="p0115"><italic>The continuum disease-free equilibria</italic> (<inline-formula><mml:math id="M128" altimg="si55.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <italic>of the model</italic> (2.1) <italic>is globally-asymptotically stable in</italic>
<inline-formula><mml:math id="M129" altimg="si82.svg"><mml:mtext>&#x003a9;</mml:mtext></mml:math></inline-formula>
<italic>if</italic>
<inline-formula><mml:math id="M130" altimg="si83.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>.</p></statement></p><p id="p0120">The <xref rid="enun_Proof" ref-type="statement">Proof</xref> to <xref rid="enun_Theorem_3_2" ref-type="statement">Theorem 3.2</xref>, based on using Lyapunov function theory, is given in <xref rid="appsec1" ref-type="sec">Appendix A</xref>. Here, too, the requirement <inline-formula><mml:math id="M131" altimg="si83.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> is sufficient, and not necessary, for the elimination of the pandemic. The epidemiological implication of this result is that COVID-19 elimination is independent of the initial sizes of the sub-populations of the model (i.e., the initial number of infected individuals introduced into the community does not have to be within the basin of attraction of the continuum of the disease-free equilibria, <inline-formula><mml:math id="M132" altimg="si55.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> of the model).</p><p id="p0125">In the absence of control interventions (i.e., no face mask usage and vaccination) in the community vaccination, the control reproduction number (<inline-formula><mml:math id="M133" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) (3.1) reduces to the basic reproduction number (denoted by <inline-formula><mml:math id="M134" altimg="si84.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>), given by:<disp-formula id="fd3_3"><label>(3.3)</label><mml:math id="M135" display="block" altimg="si85.svg" alttext="Equation 3.3."><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:msub><mml:mo stretchy="true">|</mml:mo><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mo linebreak="badbreak">&#x02217;</mml:mo></mml:msubsup><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="p0130">The quantity <inline-formula><mml:math id="M136" altimg="si84.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> represents the average number of new infections generated by a typical COVID-19 infected individual introduced into a completely susceptible population during the duration of his/her infectiousness. It is convenient to define the following quantity<disp-formula id="fd3_4"><label>(3.4)</label><mml:math id="M137" display="block" altimg="si86.svg" alttext="Equation 3.4."><mml:mrow><mml:msubsup><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:msub><mml:mo stretchy="true">|</mml:mo><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0135">which represents the control reproduction number of the model in the absence of face masks usage in the community.</p></sec></sec><sec id="sec3.2"><label>3.2</label><title>Model fitting and parameter estimation</title><p id="p0140">Some of the parameters of the model (2.1) were obtained either from the literature, or assumed based on publicly-available COVID-19 related information (<xref rid="tbl3" ref-type="table">Table 3</xref>(a)). For the six parameters whose numerical values are not known, namely the community contact rates (<inline-formula><mml:math id="M138" altimg="si87.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M139" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), the hospitalization rate of symptomatic individuals (<inline-formula><mml:math id="M140" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), mask compliance (<inline-formula><mml:math id="M141" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), and the COVID-19-related mortality rate of hospitalized individuals (<inline-formula><mml:math id="M142" altimg="si89.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), we estimated them using the COVID-19 mortality data for the US from March 1, 2020 to June 23, 2020 (<xref rid="bib6" ref-type="bibr">Centers for Disease Control and Prevention, 2019</xref>; <xref rid="bib10" ref-type="bibr">Dong, Du, &#x00026; Gardner, 2020a</xref>, <xref rid="bib11" ref-type="bibr">Dong, Du, &#x00026; Gardner, 2020</xref>; <xref rid="bib10" ref-type="bibr">Dong et&#x000a0;al., 2020a</xref>, <xref rid="bib11" ref-type="bibr">Dong, Du, &#x00026; Gardner, 2020</xref>; <xref rid="bib30" ref-type="bibr">World Health Organization, 2019</xref>). Although the first documented COVID-19 case in the US was reported January 20, 2020 (<xref rid="bib17" ref-type="bibr">Holshue et&#x000a0;al., 2020</xref>), there were less than 30 confirmed cases in the US by March 1, 2020 (<xref rid="bib10" ref-type="bibr">Dong et&#x000a0;al., 2020a</xref>, <xref rid="bib11" ref-type="bibr">Dong, Du, &#x00026; Gardner, 2020</xref>). Hence, we used data from March 1 onward in estimating our parameters, and we also start all our simulations from March 1. Also, since the mortality data was collected when no vaccination program is in place, we fitted these parameters to the special case of the model (2.1) without vaccination. To calibrate the six parameters, we used a nonlinear least squares method to determine the set of parameters that minimizes the sum of the squares of the differences between the cumulative death predictions of the vaccination-free version of the model (2.1) and the observed cumulative COVID-19 mortality. The result obtained is depicted in <xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref> (left panel). Furthermore, the observed daily deaths are plotted alongside the predicted daily deaths generated using the vaccination-free version of the model (2.1) with the parameter values obtained from the fitting of the cumulative cases (right panel of <xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). The values of the calibrated parameters obtained are tabulated in <xref rid="tbl3" ref-type="table">Table 3</xref>(b). Since no vaccine-related data for COVID-19 are currently available, we assumed that the hypothetical vaccine considered in this study has a baseline protective efficacy of 80% (i.e., we set <inline-formula><mml:math id="M143" altimg="si90.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula>). Further, we assume the baseline value of the vaccination rate (<inline-formula><mml:math id="M144" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) is 0.0203 <italic>per</italic> day.<table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Parameters of the model (2.1).</p></caption><alt-text id="alttext0060">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="3">(a) Parameter values from the literature (and those assumed)<hr/></th></tr><tr><th><bold>Parameter</bold></th><th><bold>Default values</bold></th><th><bold>Reference</bold></th></tr></thead><tbody><tr><td align="left"><inline-formula><mml:math id="M145" altimg="si48.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.5 (dimensionless)</td><td align="left">Estimated from (<xref rid="bib8" ref-type="bibr">Davies et&#x000a0;al., 2013</xref>)</td></tr><tr><td align="left"><inline-formula><mml:math id="M146" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.8 (dimensionless)</td><td align="left">Assumed</td></tr><tr><td align="left"><inline-formula><mml:math id="M147" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.0203 day<sup>&#x02212;1</sup></td><td align="left">Assumed</td></tr><tr><td align="left"><inline-formula><mml:math id="M148" altimg="si26.svg"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">1/4 day<sup>&#x02212;1</sup></td><td align="left">Adapted from (<xref rid="bib7" ref-type="bibr">Center for Disease Control and Prevention, n.d.</xref>)</td></tr><tr><td align="left"><inline-formula><mml:math id="M149" altimg="si28.svg"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">1/2 day<sup>&#x02212;1</sup></td><td align="left">Adapted from (<xref rid="bib7" ref-type="bibr">Center for Disease Control and Prevention, n.d.</xref>)</td></tr><tr><td align="left">R</td><td align="left">0.35</td><td align="left"/></tr><tr><td align="left"><inline-formula><mml:math id="M150" altimg="si95.svg"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">1/7 day<sup>&#x02212;1</sup></td><td align="left">(<xref rid="bib27" ref-type="bibr">Tang et&#x000a0;al., 2020</xref>; <xref rid="bib33" ref-type="bibr">Zhou et&#x000a0;al., 2020</xref>)</td></tr><tr><td align="left"><inline-formula><mml:math id="M151" altimg="si96.svg"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">1/7 day<sup>&#x02212;1</sup></td><td align="left">(<xref rid="bib27" ref-type="bibr">Tang et&#x000a0;al., 2020</xref>; <xref rid="bib33" ref-type="bibr">Zhou et&#x000a0;al., 2020</xref>)</td></tr><tr><td align="left"><inline-formula><mml:math id="M152" altimg="si97.svg"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">1/14 day<sup>&#x02212;1</sup></td><td align="left">(<xref rid="bib27" ref-type="bibr">Tang et&#x000a0;al., 2020</xref>; <xref rid="bib33" ref-type="bibr">Zhou et&#x000a0;al., 2020</xref>)</td></tr><tr><td align="left"><inline-formula><mml:math id="M153" altimg="si98.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left"><inline-formula><mml:math id="M154" altimg="si99.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula> day<sup>&#x02212;1</sup></td><td align="left">Estimated</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="2">(b) Fitted parameters<hr/></th></tr><tr><th><bold>Parameter</bold></th><th><bold>Fitted value</bold></th></tr></thead><tbody><tr><td align="left"><inline-formula><mml:math id="M155" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.1004 day<sup>&#x02212;1</sup></td></tr><tr><td align="left"><inline-formula><mml:math id="M156" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.7701 day<sup>&#x02212;1</sup></td></tr><tr><td align="left"><inline-formula><mml:math id="M157" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.3214 day<sup>&#x02212;1</sup></td></tr><tr><td align="left"><inline-formula><mml:math id="M158" altimg="si35.svg"><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.0514 day<sup>&#x02212;1</sup></td></tr><tr><td align="left"><inline-formula><mml:math id="M159" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.1704 (dimensionless)</td></tr><tr><td align="left"><inline-formula><mml:math id="M160" altimg="si89.svg"><mml:mrow><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula></td><td align="left">0.0001 day<sup>&#x02212;1</sup></td></tr></tbody></table></table-wrap><fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p>(a) Data fitting of the model (2.1) in the absence of vaccination using COVID-19 mortality data for the US (<xref rid="bib6" ref-type="bibr">Centers for Disease Control and Prevention, 2019</xref>; <xref rid="bib30" ref-type="bibr">World Health Organization, 2019</xref>). (b) Simulations of the model (2.1) (using the estimated parameters) illustrating the daily mortality curve. The red dots represent data points, while the solid blue line represent predictions of death from model (2.1) for the period between March 1, 2020 through June 23, 2020.</p></caption><alt-text id="alttext0015">Fig.&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p><p id="p0145">It is noteworthy from the fitted parameters in <xref rid="tbl3" ref-type="table">Table 3</xref> (b) that the sum of the fitted values of the community contact rates for the pre-symptomatic (<inline-formula><mml:math id="M161" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and asymptomatically-infectious individuals (<inline-formula><mml:math id="M162" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) overwhelmingly exceeds that for the symptomatically-infectious individuals (<inline-formula><mml:math id="M163" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). Thus, our fitting suggests that pre-symptomatic and asymptomatic infectious individuals are the overwhelming drivers of the pandemic in the US. In other words, the vast majority of the COVID-19 infections in the US is caused by COVID-19-infected individuals who are unaware of their infection status (i.e., those in the <inline-formula><mml:math id="M164" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M165" altimg="si13.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> classes). Tindale et&#x000a0;al. (<xref rid="bib28" ref-type="bibr">Tindale et&#x000a0;al., 2020</xref>) also showed that pre-symptomatic transmission played a significant role in COVID-19 dynamics in Singapore (accounting for 40-<inline-formula><mml:math id="M166" altimg="si93.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> of transmissions) and Tianjin, China (60-<inline-formula><mml:math id="M167" altimg="si94.svg"><mml:mrow><mml:mn>80</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> of transmissions).</p></sec><sec id="sec3.3"><label>3.3</label><title>Vaccine-induced herd immunity threshold</title><p id="p0150">For vaccine-preventable diseases, not all susceptible individuals can be immunized for various reasons, such as they are too young to be vaccinated (vaccinating infants or young children can, sometimes, harm the infants/children), they have co-morbidities and weakened immune system (and vaccinating may make their prognosis worse), they are of advanced age or they opt out for cultural, traditional or religious reasons. The question then is what is the minimum proportion of those we can vaccinate that we need to vaccinate so that those that we cannot vaccinate can be protected from developing severe disease or dying of the disease. The notion of <italic>herd immunity</italic> in the transmission dynamics is associated with the indirect protection, against acquisition of a communicable disease, members of the community receive when a large percentage of the population has become immune to the infectious disease due to natural recovery from prior infection or vaccination (<xref rid="bib1" ref-type="bibr">Anderson, 1992</xref>; <xref rid="bib2" ref-type="bibr">Anderson &#x00026; May 1985</xref>). The consequence of herd immunity is that individuals who are not immune (e.g., those who cannot be vaccinated or those who have not been infected yet) receive some protection against the acquisition of the disease. The safest and fastest way to achieve herd immunity is obviously vaccination. It should, however, be mentioned that Sweden employed the other mechanism for achieving herd immunity in the context of COVID-19 dynamics in Sweden (<xref rid="bib15" ref-type="bibr">Friedman, 2020</xref>). In other words, the Swedish public health agencies aimed to build herd immunity by not implementing the basic community transmission reduction strategies (e.g., social distancing, community lockdowns, use of face masks in public, contact tracing etc.) implemented in almost every country or community that is hard-hit with the COVID-19 pandemic, opting, instead, to allow individuals to acquire infection and, hopefully, recover from it. Although some level of this <italic>natural herd immunity</italic> has been achieved in Sweden, the COVID-induced mortality recorded in Sweden far exceed those recorded for neighbouring Scandinavian countries that implemented the aforementioned non-pharmaceutical interventions (<xref rid="bib15" ref-type="bibr">Friedman, 2020</xref>).</p><p id="p0155">In this section, a theoretical condition for achieving community-wide vaccine-induced herd immunity is derived. Let <inline-formula><mml:math id="M168" altimg="si100.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula> be the fraction of unvaccinated susceptible individuals that have been vaccinated at the disease-free steady-state. It follows that the control reproduction number (<inline-formula><mml:math id="M169" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) can then be re-written, in terms of <inline-formula><mml:math id="M170" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, as follows:<disp-formula id="fd3_5"><label>(3.5)</label><mml:math id="M171" display="block" altimg="si102.svg" alttext="Equation 3.5."><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0160">which can be simplified as (for the special case with <inline-formula><mml:math id="M172" altimg="si151.svg"><mml:mi mathvariant="script">R</mml:mi></mml:math></inline-formula>* being infinitesimally small in comparison to the total initial population N(0))<disp-formula id="fd3_6"><label>(3.6)</label><mml:math id="M173" display="block" altimg="si103.svg" alttext="Equation 3.6."><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02248;</mml:mo><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0165">Setting <inline-formula><mml:math id="M174" altimg="si104.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> in <xref rid="fd3_6" ref-type="disp-formula">(3.6)</xref>, and solving for <inline-formula><mml:math id="M175" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, gives the following vaccine-induced herd immunity threshold for the model (2.1):<disp-formula id="fd3_7"><label>(3.7)</label><mml:math id="M176" display="block" altimg="si105.svg" alttext="Equation 3.7."><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02248;</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mspace width="0.25em"/><mml:mtext>with</mml:mtext><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak">&#x02260;</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0170">It follows from <xref rid="fd3_6" ref-type="disp-formula">(3.6)</xref>, <xref rid="fd3_7" ref-type="disp-formula">(3.7)</xref> that <inline-formula><mml:math id="M177" altimg="si106.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mo linebreak="badbreak">&#x0003e;</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> whenever <inline-formula><mml:math id="M178" altimg="si107.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mo linebreak="badbreak">&#x0003c;</mml:mo><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>. This implies that if <inline-formula><mml:math id="M179" altimg="si108.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, then the epidemic dies out (in line with Theorems 3.1 and 3.2). Furthermore, if <inline-formula><mml:math id="M180" altimg="si109.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, then the epidemic rises, reaches a peak, and eventually declines to zero (in line with <xref rid="enun_Theorem_3_1" ref-type="statement">Theorem 3.1</xref>).</p><p id="p0175">In order to obtain the projected value of the vaccine-derived community herd immunity threshold for the US, we compute the value of basic reproduction number (<inline-formula><mml:math id="M181" altimg="si84.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>), from Equation <xref rid="fd3_3" ref-type="disp-formula">(3.3)</xref> and using the baseline values of the community contact rates (<inline-formula><mml:math id="M182" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M183" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M184" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and other parameters in <xref rid="tbl2" ref-type="table">Table 2</xref>. This gives <inline-formula><mml:math id="M185" altimg="si110.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>3.16</mml:mn></mml:mrow></mml:math></inline-formula>. Substituting this value of <inline-formula><mml:math id="M186" altimg="si84.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> into (3.7), and noting that the vaccine efficacy is assumed to be 80% (i.e., <inline-formula><mml:math id="M187" altimg="si90.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></inline-formula>) and the baseline values of face masks efficacy and compliance given in <xref rid="tbl3" ref-type="table">Table 3</xref> (i.e., <inline-formula><mml:math id="M188" altimg="si111.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M189" altimg="si112.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.1704</mml:mn></mml:mrow></mml:math></inline-formula>, respectively), shows that the vaccine-derived community herd immunity threshold for the US is approximately 82% (see <xref rid="tbl4" ref-type="table">Table 4</xref>). The epidemiological implication of this result is that the pandemic can be effectively controlled (i.e., community transmission of COVID-19 can be significantly curtailed or the disease can be eliminated) if at least 82% of the susceptible US population is vaccinated.<table-wrap position="float" id="tbl4"><label>Table 4</label><caption><p>Community herd immunity threshold (<inline-formula><mml:math id="M190" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) for the US for various levels of mask compliance (<inline-formula><mml:math id="M191" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref>.</p></caption><alt-text id="alttext0065">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Mask compliance percentage (<inline-formula><mml:math id="M192" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>)</th><th>0%</th><th><inline-formula><mml:math id="M193" altimg="si114.svg"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></th><th>17.04% (baseline)</th><th><inline-formula><mml:math id="M194" altimg="si115.svg"><mml:mrow><mml:mn>30</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></th><th><inline-formula><mml:math id="M195" altimg="si93.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></th><th><inline-formula><mml:math id="M196" altimg="si116.svg"><mml:mrow><mml:mn>100</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></th></tr></thead><tbody><tr><td align="left">Herd immunity threshold (<inline-formula><mml:math id="M197" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>)</td><td align="left">85.4%</td><td align="left">83.4%</td><td align="left"><inline-formula><mml:math id="M198" altimg="si117.svg"><mml:mrow><mml:mn>81.8</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></td><td align="left"><inline-formula><mml:math id="M199" altimg="si118.svg"><mml:mrow><mml:mn>78.5</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></td><td align="left"><inline-formula><mml:math id="M200" altimg="si119.svg"><mml:mrow><mml:mn>72.3</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></td><td align="left"><inline-formula><mml:math id="M201" altimg="si120.svg"><mml:mrow><mml:mn>45.9</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula></td></tr></tbody></table></table-wrap></p><p id="p0180">The aforementioned required vaccine coverage herd immunity percentage is certainly on the high side, and may not be realistically attainable. In fact, Dr. Anthony Fauci, a member of the US Presidential Task Force on COVID-19, stated on June 29, 2020 that the hypothetical anti-COVID-19 vaccine may not reach the required high immunity in the US if many people refuse to get it (<xref rid="bib3" ref-type="bibr">Cable News Network, 2020</xref>). One way to get around this need for high vaccine coverage to achieve high immunity is to combine the vaccination program with another anti-COVID-19 intervention, such as the use of face masks in public. <xref rid="tbl4" ref-type="table">Table 4</xref> shows that the required herd immunity threshold decreased to (perhaps a more realistically-attainable) <inline-formula><mml:math id="M202" altimg="si113.svg"><mml:mrow><mml:mn>72</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> if half the US population wears face masks in public. Further, only 46% of the US population would need to be vaccinated if everyone wears face mask in public. Thus, these simulations show that combining the vaccination program (using the hypothetical anti-COVID-19 vaccine with assumed efficacy of 80%) with a public face mask use strategy significantly enhances the prospect of COVID-19 elimination in the US.</p><p id="p0185"><xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref> depicts the cumulative mortality as a function of time for various values of the steady-state vaccination coverage (<inline-formula><mml:math id="M203" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). This figure shows an increase in the cumulative mortality when <inline-formula><mml:math id="M204" altimg="si109.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> and a decrease when <inline-formula><mml:math id="M205" altimg="si108.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> (it should be mentioned that this figure was generated for the case where the vaccination program is implemented on March 1, 2020; this explains why the cumulative mortality numbers generated from the model are much lower than the mortality numbers actually recorded in the US over the same time period). It is worth mentioning that our results for the herd immunity threshold are subject to the homogeneous mixing assumption made in the formulation of the model (2.1). It is quite possible that the required herd immunity threshold for the US may change (i.e., be lower than what we estimated) if the homogeneous mixing assumption is relaxed (i.e., if heterogeneities in mixing, perhaps based on age or socio-economic status, is incorporated into the model).<fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p>Simulations of the model (2.1), showing the cumulative COVID-19 mortality as a function of time for various levels of herd immunity threshold (<inline-formula><mml:math id="M206" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). (a) <inline-formula><mml:math id="M207" altimg="si121.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mspace width="0.25em"/><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>r</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0.2</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (b) <inline-formula><mml:math id="M208" altimg="si122.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mspace width="0.25em"/><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>r</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0.35</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (c) <inline-formula><mml:math id="M209" altimg="si123.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003e;</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>v</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mspace width="0.25em"/><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>r</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0.7</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Other parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref>. For these simulations, the vaccination program is assumed to be implemented at the onset of the pandemic (starting March 1, 2020).</p></caption><alt-text id="alttext0020">Fig.&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Numerical simulations of vaccine impact</title><p id="p0190">The model (2.1) is now simulated to assess the population-level impact of the hypothetical imperfect anti-COVID-19 vaccine in the US. The population-level impact of the vaccination rate (<inline-formula><mml:math id="M210" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) on the burden of the pandemic is monitored first of all. In these simulations, the public face mask use strategy is not implemented. The model (2.1) is then simulated using the baseline parameter values in <xref rid="tbl3" ref-type="table">Table 3</xref> (with <inline-formula><mml:math id="M211" altimg="si124.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>) and various values of <inline-formula><mml:math id="M212" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. The results obtained, depicted in <xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>, show that, for the worst-case scenario without vaccination and face masks usage in public (i.e., the model (2.1) with <inline-formula><mml:math id="M213" altimg="si125.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>), the US could record up to 110,000 cumulative deaths at the pandemic peak <xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>(a). The corresponding projected daily mortality is 2400 <xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>(b). These simulations show a dramatic reduction in the cumulative and the daily COVID-induced mortality (in comparison to the worst-case scenario without vaccination and mask usage) with increasing values of the vaccination rate <inline-formula><mml:math id="M214" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> (from its baseline value). In particular, a 10% increase in the baseline value of <inline-formula><mml:math id="M215" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> for the US resulted in a decrease in the cumulative number of deaths at the pandemic peak from 120,000 to 46,000 (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref> (a)). Furthermore, this corresponds to a decrease in the projected daily mortality from 2400 to 700, representing a <inline-formula><mml:math id="M216" altimg="si126.svg"><mml:mrow><mml:mn>71</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> reduction (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref> (b)). Similarly, a 30% increase in the baseline value of <inline-formula><mml:math id="M217" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> resulted in a marked reduction of the daily deaths at the pandemic peak to 580 (corresponding to a decrease in the projected cumulative mortality from 120,000 to 25,000). Thus, these simulations suggest that a significantly large increase in vaccination rate (from baseline) is necessarily needed to eliminate COVID-19 in the US using the hypothetical vaccine.<fig id="fig4"><label>Fig.&#x000a0;4</label><caption><p>Effect of vaccination coverage. Simulations of the model (2.1) showing the effect of the vaccination rate (<inline-formula><mml:math id="M218" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) on COVID-19 burden measure in terms of (a) cumulative deaths and (b) daily deaths. Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref>, with <inline-formula><mml:math id="M219" altimg="si124.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> and various values of <inline-formula><mml:math id="M220" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>.</p></caption><alt-text id="alttext0025">Fig.&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p><p id="p0195">The model (2.1) is simulated to allow for the assessment of the impact of social distancing measures (aimed at reducing community transmission) with the implementation of vaccination and public mask usage in the community. We consider three levels of social distancing effectiveness, namely mild, moderate and high (strict). We model these effectiveness levels in terms of reduction in the community contact rate parameters (<inline-formula><mml:math id="M221" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M222" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M223" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), in comparison to their baseline values. In particular, we set mild, moderate, and strict (high) social distancing to correspond to a 10%, 30%, and 50% reduction, respectively, in the values of the contact rate parameters, in relation to their baseline values in <xref rid="tbl3" ref-type="table">Table 3</xref>. The simulation results obtained, depicted in <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>, shows a marked decrease in disease burden (measured in terms of daily and cumulative COVID-induced mortality) with increasing effectiveness of social distancing, as expected. For instance, while <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> shows that up to 51,000 cumulative mortality can be recorded if social distancing measures were not implemented, the cumulative mortality dramatically decreases to about 5000 (representing about <inline-formula><mml:math id="M224" altimg="si127.svg"><mml:mrow><mml:mn>90</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> reduction in cumulative mortality) if strict social distancing measures were implemented (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> (a)). Similarly, <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> shows that up to 810 daily mortality can be recorded in the US if social distancing measures were not implemented, the daily mortality dramatically decreases to about 70 (representing about <inline-formula><mml:math id="M225" altimg="si128.svg"><mml:mrow><mml:mn>91</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> reduction in daily mortality) if strict social distancing measures were implemented (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> (b)). Thus, these simulations suggest that the implementation of the vaccination program alongside mask use and social distancing is more effective than if only the first two strategies are used.<fig id="fig5"><label>Fig.&#x000a0;5</label><caption><p>Simulations of the model (2.1) for the impact various effectiveness of social distancing control measures in the presence of vaccination on (a) cumulative deaths, (b) daily deaths. Mild, moderate, and strict (high) social distancing corresponds to 10%, 30%, and 50%, decrease in the values of the community contact rates <inline-formula><mml:math id="M226" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M227" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M228" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> from their baseline values, respectively. Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref>.</p></caption><alt-text id="alttext0030">Fig.&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p><p id="p0200">Simulations were also carried out to assess the impact of vaccine efficacy and coverage on this disease dynamics. This is done for the special case of the model in the absence of the use of masks in the public (i.e., the model (2.1) with <inline-formula><mml:math id="M229" altimg="si124.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>). Specifically, a contour plot of the control reproduction number (<inline-formula><mml:math id="M230" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) of the model, as a function of coverage (<inline-formula><mml:math id="M231" altimg="si129.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> and vaccine efficacy (<inline-formula><mml:math id="M232" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), is depicted in <xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref>. This figure shows a decrease in the value of the reproduction number with increasing coverage and efficacy of the vaccine, as expected. For the assumed 80% efficacy of the hypothetical vaccine (i.e., <inline-formula><mml:math id="M233" altimg="si130.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0.8</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:math></inline-formula> in <xref rid="tbl3" ref-type="table">Table 3</xref> (a), the simulations depicted in <xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref> show that nationwide elimination of COVID-19 can be achieved (i.e., <inline-formula><mml:math id="M234" altimg="si131.svg"><mml:mrow><mml:msubsup><mml:mi mathvariant="script">R</mml:mi><mml:mn>0</mml:mn><mml:mtext>&#x02217;</mml:mtext></mml:msubsup></mml:mrow></mml:math></inline-formula> can be brought to a value below unity) if at least 85.4% of the US populace is vaccinated.<fig id="fig6"><label>Fig.&#x000a0;6</label><caption><p>Effects of vaccination as the only intervention strategy. Contour plots of the control reproduction number (<inline-formula><mml:math id="M235" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) of the model (2.1), as a function of vaccine coverage (<inline-formula><mml:math id="M236" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and vaccine efficacy (<inline-formula><mml:math id="M237" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), for the baseline scenarios in <xref rid="tbl3" ref-type="table">Table 3</xref> and in the absence of mask usage in public for the US. Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref> with <inline-formula><mml:math id="M238" altimg="si132.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>.</p></caption><alt-text id="alttext0035">Fig.&#x000a0;6</alt-text><graphic xlink:href="gr6"/></fig></p><p id="p0205">The effect of the combined implementation of vaccination and social distancing strategies, on the control reproduction number (<inline-formula><mml:math id="M239" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) of the model (2.1), is also monitored, by generating contour plots of <inline-formula><mml:math id="M240" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, as a function of vaccination coverage (<inline-formula><mml:math id="M241" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and efficacy (<inline-formula><mml:math id="M242" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), for the aforementioned three levels (low, moderate and high) of social distancing effectiveness. The results obtained, depicted in <xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref>, show that COVID-19 elimination (measured in terms of bringing <inline-formula><mml:math id="M243" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> to a value less than unity) is feasible even if social distancing is implemented at a low (mild) level of effectiveness (left panels of <xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref>). In particular, <xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref> (a) shows that, with the assumed 80% efficacy of the vaccine, the implementation of social distancing at low effectiveness level will lead to the elimination of COVID-19 if the vaccine coverage is at least 81%. This required coverage decreases with increasing effectiveness of the social distancing measures (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref> (b) and (c)).<fig id="fig7"><label>Fig.&#x000a0;7</label><caption><p>Effect of combined vaccination and social distancing strategies. Contour plots of the control reproduction number (<inline-formula><mml:math id="M244" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), as a function of vaccine coverage (<inline-formula><mml:math id="M245" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and vaccine efficacy (<inline-formula><mml:math id="M246" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) for the special case of the model (2.1) with no mask use in public. (a) mild social distancing (i.e., 10<inline-formula><mml:math id="M247" altimg="si133.svg"><mml:mtext>%</mml:mtext></mml:math></inline-formula> decrease in <inline-formula><mml:math id="M248" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M249" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M250" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). (b) Moderate social distancing (i.e., 30<inline-formula><mml:math id="M251" altimg="si133.svg"><mml:mtext>%</mml:mtext></mml:math></inline-formula> decrease in <inline-formula><mml:math id="M252" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M253" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M254" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). (c) Strict social distancing (i.e., 50<inline-formula><mml:math id="M255" altimg="si133.svg"><mml:mtext>%</mml:mtext></mml:math></inline-formula> decrease in <inline-formula><mml:math id="M256" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M257" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M258" altimg="si92.svg"><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref>.</p></caption><alt-text id="alttext0040">Fig.&#x000a0;7</alt-text><graphic xlink:href="gr7"/></fig></p><p id="p0210">Additional numerical simulations were carried out to assess the community-wide impact of the combined impact of vaccination with a public face mask use strategy (as measured in terms of reduction in the value of control reproduction number, <inline-formula><mml:math id="M259" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). The results obtained, depicted in <xref rid="fig8" ref-type="fig">Fig.&#x000a0;8</xref>, show a decrease in <inline-formula><mml:math id="M260" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> with increasing vaccine efficacy and compliance. For the fixed vaccine efficacy at 80%, our results show that if 10% of the US population wear face masks in public, the minimum vaccine coverage needed to eliminate the disease is approximately 83%. The minimum coverage needed to eliminate the pandemic decreases to 79% and 72%, respectively, if 30% and 50% of the US population wear face masks in public (<xref rid="fig8" ref-type="fig">Fig.&#x000a0;8</xref> (a), (b) and (c)). Thus, the simulations in <xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref>, <xref rid="fig8" ref-type="fig">Fig.&#x000a0;8</xref> also emphasize the fact that the prospect of COVID-19 elimination using a vaccine is greatly enhanced if the vaccination program is complemented with another anti-COVID-19 intervention (such as face masks usage in public and social distancing), particularly if the complementary intervention is implemented at moderate or high effectiveness level (i.e, implemented universally, and with high efficacy and compliance).<fig id="fig8"><label>Fig.&#x000a0;8</label><caption><p>Contour plots of the control reproduction number (<inline-formula><mml:math id="M261" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), as a function of vaccine coverage (<inline-formula><mml:math id="M262" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and vaccine efficacy (<inline-formula><mml:math id="M263" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) for (a) 10% mask compliance, (b) 30<inline-formula><mml:math id="M264" altimg="si133.svg"><mml:mtext>%</mml:mtext></mml:math></inline-formula> mask compliance, and (c) 50<inline-formula><mml:math id="M265" altimg="si133.svg"><mml:mtext>%</mml:mtext></mml:math></inline-formula> mask compliance. Parameter values used are as given in <xref rid="tbl3" ref-type="table">Table 3</xref> with various values of <inline-formula><mml:math id="M266" altimg="si47.svg"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>.</p></caption><alt-text id="alttext0045">Fig.&#x000a0;8</alt-text><graphic xlink:href="gr8"/></fig></p></sec><sec id="sec5"><label>5</label><title>Discussion and conclusions</title><p id="p0215">A novel Coronavirus (COVID-19) emerged in China in December 2019. The virus, which is caused by SARS-CoV-2, rapidly spread to over 210 countries causing over 10 million confirmed cases and 500,000 deaths globally (as of June 28, 2020). Although there are currently no safe and effective vaccine for use in humans, numerous concerted global efforts are underway aimed at developing such vaccine. In fact, a number of candidate vaccines are undergoing advanced stages of clinical trials. One of the most promising of these efforts is the candidate vaccine being developed by a research group at Oxford University, which is expected to be available as early as January 2021 (or, latest, by the spring of 2021). We developed a mathematical model for assessing the potential community-wide impact of a hypothetical imperfect vaccine against the COVID-19 pandemic in the US. The model we developed, which takes the form of a deterministic system of nonlinear differential equations, was parametrized using COVID-19 data for the US. The hypothetical vaccine was assumed to offer imperfect protective efficacy against the acquisition of COVID-19 infection.</p><p id="p0220">The model was rigorously analysed to gain insight into its dynamical features. These analyses reveal that the continuum of disease-free equilibria of the epidemic model is asymptotically-stable whenever a certain epidemiological threshold, known as the control reproduction number (denoted by <inline-formula><mml:math id="M267" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), is less than unity. The epidemiological implication of this result is that the community transmission of COVID-19 can be significantly curtailed if <inline-formula><mml:math id="M268" altimg="si77.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. In other words, the routine vaccination against COVID-19 (using the hypothetical vaccine) can lead to the effective control or elimination of the pandemic if it can bring (and maintain) <inline-formula><mml:math id="M269" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> to a value less than unity. Furthermore, threshold quantities for the community vaccine-induced herd immunity were calculated. Our computations show, using the baseline values of the parameters of the model, that at least 82% of the US population needs to be vaccinated in order to achieve nationwide vaccine-derived herd immunity. This required vaccine coverage is certainly on the high side, and may not be easily attained for so many reasons, ranging from the expected insufficient stockpile of the vaccine during the early stages of their deployment, general apathy towards vaccination and the sizable percentage of people that cannot be vaccinated for medical, personal and other reasons (in fact, Dr. Anthony Fauci, a member of the US Presidential Task Force on COVID-19 warned on June 28, 2020 that the hypothetical vaccine may not generate the required level of herd immunity if too many people in the US decide not to be vaccinated (<xref rid="bib3" ref-type="bibr">Cable News Network, 2020</xref>)). Our simulations showed that if the vaccination strategy is complemented with other public health interventions, such as a public mask use strategy for instance, the minimum herd immunity threshold required to effectively control the COVID-19 pandemic significantly reduces to a more realistically-attainable level. For example, if vaccination (using a vaccine with the assumed efficacy of 80%) is combined with a public face mask strategy with 30% mask compliance nationwide, the herd immunity threshold for the entire US decreases to 79%. In fact, this threshold decreases to only 46% if everyone in the US (who can wear a face mask) wears face mask in public. Thus, this study shows that the prospect of the effective control of COVID-19 using routine vaccination (with the hypothetical vaccine) is significantly enhanced if the vaccination program is combined with a public face mass use strategy (especially if the effectiveness and coverage of the face mask use strategy are high enough).</p><p id="p0225">We also carried out numerical simulations to measure the population-level impact of the rate at which the hypothetical vaccination is administered. The results obtained showed that the COVID-19 burden (as measured in terms of daily and cumulative COVID-induced mortality) decreases with increasing vaccination rate, as expected. Our simulations showed that high increases in the vaccination rate (from its baseline value) is necessarily needed to achieve significant reduction in disease burden. We also simulated the combined effect of implementing the routine vaccination program with social distancing (in the absence of face mask usage). We showed that COVID-19 can be effectively controlled using the two interventions even if the effectiveness level of social distancing is low (as long as the vaccine coverage is high). In particular, our simulations showed that the control reproduction number (<inline-formula><mml:math id="M270" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) can be reduced to a value less than unity (needed for the effective control of the disease, in line with the local and global asymptotic stability property of the continuum of disease-free equilibria, established in Section <xref rid="sec3" ref-type="sec">3</xref>).</p><p id="p0230">We assessed the population-level impact of combining the routine vaccination strategy with a public mask use strategy. Our simulations show a decrease in the burden of the COVID-19 pandemic (again as measured in terms of reduction in the value of the reproduction number <inline-formula><mml:math id="M271" altimg="si59.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) with increasing efficacies and compliance of the vaccine and mask usage. It was shown that if the vaccine efficacy is fixed at the assumed 80% and mask compliance is fixed at the low value of 10%, COVID-19 can be eliminated if the vaccine coverage is at least 83%. The vaccine coverage decreases to 79%, 72%, and 46%, respectively, if mask use compliance is increased to 30%, 50%, and 100%. Again, these result confirmed that COVID-19 elimination is more feasible if the vaccination program is combined with another intervention (face mask use in public, in this case).</p><p id="p0235">In summary, this study shows that the prospect of eliminating COVID-19 in the US using the imperfect hypothetical vaccine is promising. This prospect is greatly enhanced if the vaccination program is combined with other interventions that limit community transmission, such as social distancing and face mask use in public. Certain factors may affect the results we presented in this study. The first is that the absence of vaccine-related data forced us to make assumptions on the expected efficacy of the hypothetical vaccine (<inline-formula><mml:math id="M272" altimg="si49.svg"><mml:mrow><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>), as well as the rate at which it will be administered in the US (<inline-formula><mml:math id="M273" altimg="si21.svg"><mml:mrow><mml:msub><mml:mi>&#x003be;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>). In particular, we assumed a vaccine efficacy of <inline-formula><mml:math id="M274" altimg="si94.svg"><mml:mrow><mml:mn>80</mml:mn><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula>, which may be higher than the efficacy of the COVID-19 vaccine we end up having in the future. Second, the model we developed in this study is based on assuming a well-mixed population. This simplifying homogeneous-mixing assumption (needed for mathematical tractability) constitutes another limitation of the study (in particular, the value for the vaccine-derived herd immunity threshold we estimated may be lowed if mixing heterogeneities are incorporated into the model). The authors plan to address these heterogeneities in a future study.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0240">None.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>R.M.</given-names></name></person-group><article-title>The concept of herd immunity and the design of community-based immunization programmes</article-title><source>Vaccine</source><volume>10</volume><year>1992</year><fpage>928</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">1471414</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>R.M.</given-names></name><name><surname>May</surname><given-names>R.M.</given-names></name></person-group><article-title>Vaccination and herd immunity to infectious diseases</article-title><source>Nature</source><volume>318</volume><year>1985</year><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">3906406</pub-id></element-citation></ref><ref id="bib3"><mixed-citation publication-type="other" id="sref3">Cable News Network, &#x0201c;Fauci says covid-19 vaccine may not get us to herd immunity if too many people refuse to get it,&#x0201d; CNN (Assessed on June 29, 2020). (Online Version).</mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="other" id="sref4">E. Callaway, &#x0201c;Scores of coronavirus vaccines are in competition &#x02013;&#x02013; how will scientists choose the best?&#x0201d; A Natureresearch Journal (Assessed on April 30, 2020).</mixed-citation></ref><ref id="bib5"><element-citation publication-type="book" id="sref5"><source>Center for Systems Science and Engineering at Johns Hopkins University. COVID-19</source><year>2020</year><publisher-name>JHU CSSE</publisher-name><comment>(Online Version)</comment></element-citation></ref><ref id="bib6"><mixed-citation publication-type="other" id="sref6">Centers for Disease Control and Prevention, &#x0201c;Coronavirus disease 2019 (COVID-19),&#x0201d; National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases (Accessed on March 4, 2020). (Online Version).</mixed-citation></ref><ref id="bib7"><element-citation publication-type="book" id="sref7"><person-group person-group-type="author"><name><surname>Center for Disease Control and Prevention</surname></name></person-group><chapter-title>Covid-19 pandemic planning scenarios</chapter-title><year>June 6, 2020</year><publisher-name>National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases</publisher-name><comment>(Online Version)</comment></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>K.-A.</given-names></name><name><surname>Giri</surname><given-names>K.</given-names></name><name><surname>Kafatos</surname><given-names>G.</given-names></name><name><surname>Walker</surname><given-names>J.</given-names></name><name><surname>Bennett</surname><given-names>A.</given-names></name></person-group><article-title>Testing the efficacy of homemade masks: Would they protect in an influenza pandemic?</article-title><source>Disaster Medicine and Public Health Preparedness</source><volume>7</volume><year>2013</year><fpage>413</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">24229526</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Diekmann</surname><given-names>O.</given-names></name><name><surname>Heesterbeek</surname><given-names>J.A.P.</given-names></name><name><surname>Metz</surname><given-names>J.A.</given-names></name></person-group><article-title>On the definition and the computation of the basic reproduction ratio R<sub>0</sub>in models for infectious diseases in heterogeneous populations</article-title><source>Journal of Mathematical Biology</source><volume>28</volume><year>1990</year><fpage>365</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">2117040</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Gardner</surname><given-names>L.</given-names></name></person-group><article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title><source>The Lancet Infectious Diseases</source><year>2020</year></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>van den Driessche</surname><given-names>P.</given-names></name><name><surname>Watmough</surname><given-names>J.</given-names></name></person-group><article-title>Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission</article-title><source>Mathematical Biosciences</source><volume>180</volume><year>2002</year><fpage>29</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12387915</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Gardner</surname><given-names>L.</given-names></name></person-group><article-title>Coronavirus COVID-19 global cases by Johns Hopkins CSSE</article-title><source>The Lancet Infectious Diseases</source><year>2020</year><comment>Online Version</comment></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Eikenberry</surname><given-names>S.E.</given-names></name><name><surname>Muncuso</surname><given-names>M.</given-names></name><name><surname>Iboi</surname><given-names>E.</given-names></name><name><surname>Phan</surname><given-names>T.</given-names></name><name><surname>Kostelich</surname><given-names>E.</given-names></name><name><surname>Kuang</surname><given-names>Y.</given-names></name><name><surname>Gumel</surname><given-names>A.B.</given-names></name></person-group><article-title>To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the covid-19 pandemic</article-title><source>Infectious Disease Modeling</source><volume>5</volume><year>2020</year><fpage>293</fpage><lpage>308</lpage></element-citation></ref><ref id="bib14"><element-citation publication-type="book" id="sref14"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>N.M.</given-names></name><name><surname>Laydon</surname><given-names>D.</given-names></name><name><surname>Nedjati-Gilani</surname><given-names>G.</given-names></name><name><surname>Imai</surname><given-names>N.</given-names></name><name><surname>Ainslie</surname><given-names>K.</given-names></name><name><surname>Baguelin</surname><given-names>M.</given-names></name><name><surname>Bhatia</surname><given-names>S.</given-names></name><name><surname>Boonyasiri</surname><given-names>A.</given-names></name><name><surname>Cucunub&#x000e1;</surname><given-names>Z.</given-names></name><name><surname>Cuomo-Dannenburg</surname><given-names>G.</given-names></name></person-group><chapter-title>Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand</chapter-title><year>2020</year><publisher-name>Imperial College COVID-19 Response Team</publisher-name><publisher-loc>&#x0201d; London</publisher-loc><comment>March 16</comment></element-citation></ref><ref id="bib15"><mixed-citation publication-type="other" id="sref15">T. L. Friedman, &#x0201c;Is Sweden doing it right?&#x0201d; New York Times (Assessed on May 4, 2020). (Online Version).</mixed-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Hellewell</surname><given-names>J.</given-names></name><name><surname>Abbott</surname><given-names>S.</given-names></name><name><surname>Gimma</surname><given-names>A.</given-names></name><name><surname>Bosse</surname><given-names>N.I.</given-names></name><name><surname>Jarvis</surname><given-names>C.I.</given-names></name><name><surname>Russell</surname><given-names>T.W.</given-names></name><name><surname>Munday</surname><given-names>J.D.</given-names></name><name><surname>Kucharski</surname><given-names>A.J.</given-names></name><name><surname>Edmunds</surname><given-names>W.J.</given-names></name><name><surname>Sun</surname><given-names>F.</given-names></name></person-group><article-title>Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts</article-title><source>The Lancet Global Health</source><year>2020</year></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Holshue</surname><given-names>M.L.</given-names></name><name><surname>DeBolt</surname><given-names>C.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name><name><surname>Lofy</surname><given-names>K.H.</given-names></name><name><surname>Wiesman</surname><given-names>J.</given-names></name><name><surname>Bruce</surname><given-names>H.</given-names></name><name><surname>Spitters</surname><given-names>C.</given-names></name><name><surname>Ericson</surname><given-names>K.</given-names></name><name><surname>Wilkerson</surname><given-names>S.</given-names></name><name><surname>Tural</surname><given-names>A.</given-names></name></person-group><article-title>&#x0201c;First case of 2019 novel coronavirus in the United States,&#x0201d; New England</article-title><source>Journal of Medicine</source><year>2020</year></element-citation></ref><ref id="bib18"><element-citation publication-type="book" id="sref18"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>D.</given-names></name></person-group><chapter-title>In race for a coronavirus vaccine, an Oxford group leaps ahead</chapter-title><year>May 2, 2020</year><publisher-name>New York Times</publisher-name><comment>Online Version</comment></element-citation></ref><ref id="bib19"><mixed-citation publication-type="other" id="sref19">S. Knvul and T. Katie, &#x0201c;More coronavirus vaccines and treatments move toward human trials,&#x0201d; New York Times (Accessed on May 2, 2020). (Online Version).</mixed-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Kucharski</surname><given-names>A.J.</given-names></name><name><surname>Russell</surname><given-names>T.W.</given-names></name><name><surname>Diamond</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Edmunds</surname><given-names>J.</given-names></name><name><surname>Funk</surname><given-names>S.</given-names></name><name><surname>Eggo</surname><given-names>R.M.</given-names></name><name><surname>Sun</surname><given-names>F.</given-names></name><name><surname>Jit</surname><given-names>M.</given-names></name><name><surname>Munday</surname><given-names>J.D.</given-names></name></person-group><article-title>Early dynamics of transmission and control of COVID-19: A mathematical modelling study</article-title><source>The Lancet Infectious Diseases</source><year>2020</year></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>R.</given-names></name><name><surname>Leung</surname><given-names>K.S.</given-names></name><name><surname>Lau</surname><given-names>E.H.</given-names></name><name><surname>Wong</surname><given-names>J.Y.</given-names></name></person-group><article-title>&#x0201c;Early transmission dynamics in Wuhan, China, of novel coronavirus&#x02013;infected pneumonia</article-title><source>New England Journal of Medicine</source><year>2020</year></element-citation></ref><ref id="bib22"><element-citation publication-type="book" id="sref22"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>S.</given-names></name></person-group><chapter-title>U.S. Jobless rate may soar to 30%</chapter-title><year>May 2, 2020</year><publisher-name>Bloomberg Report</publisher-name><comment>(Online Version)</comment></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Mizumoto</surname><given-names>K.</given-names></name><name><surname>Chowell</surname><given-names>G.</given-names></name></person-group><article-title>Transmission potential of the novel coronavirus (COVID-19) onboard the Diamond princess cruises ship, 2020</article-title><source>Infectious Disease Modelling</source><year>2020</year></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Ngonghala</surname><given-names>C.N.</given-names></name><name><surname>Iboi</surname><given-names>E.</given-names></name><name><surname>Eikenberry</surname><given-names>S.</given-names></name><name><surname>Scotch</surname><given-names>M.</given-names></name><name><surname>MacIntyre</surname><given-names>C.R.</given-names></name><name><surname>Bonds</surname><given-names>M.H.</given-names></name><name><surname>Gumel</surname><given-names>A.B.</given-names></name></person-group><article-title>Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus</article-title><source>Mathematical Biosciences</source><volume>325</volume><year>2020</year><fpage>108364</fpage><pub-id pub-id-type="pmid">32360770</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="book" id="sref25"><person-group person-group-type="author"><name><surname>Nishiura</surname><given-names>H.</given-names></name><name><surname>Chowell</surname><given-names>G.</given-names></name></person-group><chapter-title>The effective reproduction number as a prelude to statistical estimation of time-dependent epidemic trends</chapter-title><source>Mathematical and statistical estimation approaches in epidemiology</source><year>2009</year><publisher-name>Springer</publisher-name><fpage>103</fpage><lpage>121</lpage></element-citation></ref><ref id="bib26"><element-citation publication-type="book" id="sref26"><person-group person-group-type="author"><name><surname>Rotman</surname><given-names>D.</given-names></name></person-group><chapter-title>Stop COVID or save the economy? We can do both</chapter-title><year>May 2, 2020</year><publisher-name>MIT Technology Review</publisher-name><comment>(Online Version)</comment></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Bragazzi</surname><given-names>N.L.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><year>2020</year><fpage>462</fpage></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Tindale</surname><given-names>L.C.</given-names></name><name><surname>Stockdale</surname><given-names>J.E.</given-names></name><name><surname>Coombe</surname><given-names>M.</given-names></name><name><surname>Garlock</surname><given-names>E.S.</given-names></name><name><surname>Lau</surname><given-names>W.Y.V.</given-names></name><name><surname>Saraswat</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Wallinga</surname><given-names>J.</given-names></name><name><surname>Colijn</surname><given-names>C.</given-names></name></person-group><article-title>Evidence for transmission of covid-19 prior to symptom onset</article-title><source>eLife</source><volume>9</volume><year>2020</year><object-id pub-id-type="publisher-id">e57149</object-id></element-citation></ref><ref id="bib29"><mixed-citation publication-type="other" id="sref29">World Health Organization, &#x0201c;Coronavirus disease (COVID-19) technical guidance,&#x0201d; WHO (Accessed on March 4, 2020). Online Version.</mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="other" id="sref30">World Health Organization, &#x0201c;reportCoronavirus disease (COVID-2019) situation reports,&#x0201d; WHO (Accessed on March 19, 2020). Online Version.</mixed-citation></ref><ref id="bib31"><element-citation publication-type="book" id="sref31"><person-group person-group-type="author"><name><surname>World Health Organization</surname></name></person-group><series>Coronavirus disease 2019 (COVID-19): Situation report</series><volume>Vol. 46</volume><year>2020</year><publisher-name>WHO</publisher-name></element-citation></ref><ref id="bib32"><mixed-citation publication-type="other" id="sref32">World Health Organization, &#x0201c;Emergencies, preparedness, response. Pneumonia of unknown origin &#x02013; China," Disease Outbreak News (5 January, (Accessed on March 5, 2020). Online Version.</mixed-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name></person-group><article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study</article-title><source>The Lancet</source><year>2020</year></element-citation></ref></ref-list><sec id="appsec1"><label>Appendix A</label><title>Proof of <xref rid="enun_Theorem_3_2" ref-type="statement">Theorem 3.2</xref></title><p id="p0250"><statement id="enun_Proof"><label>Proof</label><p id="p0255">Consider the model (2.1) with <inline-formula><mml:math id="M275" altimg="si83.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. Furthermore, consider the following linear Lyapunov function:<disp-formula id="ufd7"><mml:math id="M276" altimg="si135.svg"><mml:mrow><mml:mi mathvariant="script">L</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where,<disp-formula id="ufd8"><mml:math id="M277" altimg="si136.svg"><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mspace width="0.25em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.25em"/><mml:msub><mml:mtext>g</mml:mtext><mml:mn>4</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mtext>s</mml:mtext></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mtext>s</mml:mtext></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mtext>s</mml:mtext></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mtext>M</mml:mtext></mml:msub><mml:msub><mml:mtext>c</mml:mtext><mml:mtext>M</mml:mtext></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p id="p0260">It follows that the Lyapunov derivative is given by:<disp-formula id="ufd9"><mml:math id="M278" altimg="si137.svg"><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mi>a</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003bb;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="p0265">which can be simplified to,<disp-formula id="ufd10"><mml:math id="M279" altimg="si138.svg"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">]</mml:mo><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"/><mml:mtd columnalign="left"><mml:mo>+</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">]</mml:mo><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"/><mml:mtd columnalign="left"><mml:mo>+</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003d5;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>so that (noting that since <inline-formula><mml:math id="M280" altimg="si139.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> in <inline-formula><mml:math id="M281" altimg="si82.svg"><mml:mtext>&#x003a9;</mml:mtext></mml:math></inline-formula> and <inline-formula><mml:math id="M282" altimg="si140.svg"><mml:mrow><mml:mn>0</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mi>&#x003b5;</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, then <inline-formula><mml:math id="M283" altimg="si141.svg"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mi>v</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> for all <italic>t</italic>),<disp-formula id="ufd11"><mml:math id="M284" altimg="si142.svg"><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="badbreak">&#x02264;</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">+</mml:mo><mml:mfrac><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mi>M</mml:mi></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>&#x003c6;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>&#x003b4;</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>Hence, <inline-formula><mml:math id="M285" altimg="si143.svg"><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> if <inline-formula><mml:math id="M286" altimg="si83.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M287" altimg="si144.svg"><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> if and only if <inline-formula><mml:math id="M288" altimg="si145.svg"><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>. Therefore, <inline-formula><mml:math id="M289" altimg="si146.svg"><mml:mi mathvariant="script">L</mml:mi></mml:math></inline-formula> is a Lyapunov function for system (2.1). Substituting <inline-formula><mml:math id="M290" altimg="si145.svg"><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula> in the model (2.1) shows that <inline-formula><mml:math id="M291" altimg="si148.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mi>R</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02192;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>v</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msubsup><mml:mo>,</mml:mo><mml:mn>0,0,0,0,0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mtext>&#x02217;</mml:mtext></mml:msup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> as <inline-formula><mml:math id="M292" altimg="si79.svg"><mml:mrow><mml:mi>t</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02192;</mml:mo><mml:mi>&#x0221e;</mml:mi></mml:mrow></mml:math></inline-formula>. Furthermore, it can be shown that the largest compact invariant set in <inline-formula><mml:math id="M293" altimg="si150.svg"><mml:mrow><mml:mrow><mml:mo stretchy="true">{</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>v</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mi>R</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">&#x02208;</mml:mo><mml:mtext>&#x003a9;</mml:mtext><mml:mo>:</mml:mo><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">L</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo stretchy="true">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is the continuum of disease-free equilibria (<inline-formula><mml:math id="M294" altimg="si55.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>). Hence, it follows, by the LaSalle&#x02019;s Invariance Principle, that the continuum of disease-free equilibria of the model (2.1) is a stable global attractor in <inline-formula><mml:math id="M295" altimg="si82.svg"><mml:mtext>&#x003a9;</mml:mtext></mml:math></inline-formula> whenever <inline-formula><mml:math id="M296" altimg="si83.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">R</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>.</p></statement></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>One of the authors (<funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100007880</institution-id><institution>ABG</institution></institution-wrap></funding-source>) acknowledge the support, in part, of the <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000893</institution-id><institution>Simons Foundation</institution></institution-wrap></funding-source> (Award <inline-formula><mml:math id="M297" altimg="si134.svg"><mml:mo>#</mml:mo></mml:math></inline-formula>585022) and the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source> (Award <inline-formula><mml:math id="M298" altimg="si134.svg"><mml:mo>#</mml:mo></mml:math></inline-formula>1917512). CNN acknowledges the support of the <funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000893</institution-id><institution>Simons Foundation</institution></institution-wrap></funding-source> (Award #627346). The authors are grateful to the two anonymous reviewers and the Handling Editor for the constructive comments. The authors are grateful to Dr. Elamin H. Elbasha (Merck Inc.) for the careful reading of the manuscript and for the valuable comments on the computation of the vaccine-derived herd immunity threshold.</p></ack><fn-group><fn id="d32e1284"><p id="ntpara0010">Peer review under responsibility of KeAi Communications Co., Ltd.</p></fn></fn-group></back></article>